Bronsveld Heleen K, Peeters Paul J H L, de Groot Mark C H, de Boer Anthonius, Schmidt Marjanka K, De Bruin Marie L
Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Division Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
Prim Care Diabetes. 2017 Aug;11(4):373-382. doi: 10.1016/j.pcd.2017.02.001. Epub 2017 Feb 23.
To quantify breast cancer incidence in women with type-2 diabetes and assess age-standardized trends in invasive breast cancer incidence over time and by age groups.
A population-based cohort study was conducted using the British general practice database (Clinical Practice Research Datalink) using data from 1989 to 2012. All adult women prescribed anti-hyperglycemic medication were selected and matched (1:1) on age and clinical practice to a reference cohort without diabetes.
During approximately 1.6 million person years (py), 2371 breast cancer cases were diagnosed in the diabetes cohort (n=147,998) and 2252 in the reference cohort (n=147,998). Incidence of breast cancer, overall or by age groups, among women with diabetes remained stable over time. The (overall) age-standardized breast cancer IR per 100,000 py of the diabetes cohort (150, 95%CI:143-157) resembled that observed in the reference cohort (148, 95%CI:141-156); with an incidence rate ratio (IRR) of 1.01 (95%CI:0.94-1.08, p>0.05).
Currently, around 2880 women with type-2 diabetes are diagnosed with breast cancer per year in the United Kingdom. However, breast cancer incidence remained stable in the last 10 years and seems to be comparable in women with and without diabetes.
量化2型糖尿病女性的乳腺癌发病率,并评估浸润性乳腺癌发病率随时间及年龄组的年龄标准化趋势。
利用英国全科医疗数据库(临床实践研究数据链)进行一项基于人群的队列研究,使用1989年至2012年的数据。选取所有开具降糖药物的成年女性,并按年龄和临床实践与无糖尿病的对照队列进行1:1匹配。
在约160万人年期间,糖尿病队列(n = 147,998)中诊断出2371例乳腺癌病例,对照队列(n = 147,998)中诊断出2252例。糖尿病女性中乳腺癌的总体发病率或按年龄组划分的发病率随时间保持稳定。糖尿病队列每10万人年的(总体)年龄标准化乳腺癌发病率(150,95%CI:143 - 157)与对照队列中观察到的发病率(148,95%CI:141 - 156)相似;发病率比(IRR)为1.01(95%CI:0.94 - 1.08,p>0.05)。
目前,英国每年约有2880名2型糖尿病女性被诊断出患有乳腺癌。然而,过去10年乳腺癌发病率保持稳定,且糖尿病女性和非糖尿病女性的发病率似乎相当。